Founded in 2017, Amplitude Vascular Systems (AVS) is an early-stage medical device company that is focused on safely and effectively treating severely calcified arterial disease. AVS is the first company to develop PULSE IVL™, a device that delivers intravascular lithotripsy treatment through a balloon-based platform. It is designed to be the only minimally invasive technology that gently shatters calcium and opens the artery using a single device.
Upcoming Events
Walter E. Washington Convention Center Washington, DC TCT: Transcatheter Cardiovascular Therapeutics | Annual Meeting (crfconferences.com)
Investor Publications
We are committed to working with leading interventionalists to publish study data that supports the value of PULSE IVL™ for the treatment of severely calcified vessels.